Stevanato Group Q3 revenue beats analyst expectations

Stevanato SpA

06/11/2025 11:46

Overview

Stevanato Q3 revenue grows 9% to €303.2 mln, beating analyst expectations

Adjusted EPS for Q3 was €0.14, maintaining fiscal 2025 guidance

Revenue growth driven by high-value solutions and favorable shipment timing

Outlook

Stevanato maintains fiscal 2025 revenue guidance of €1.160 bln to €1.190 bln

Stevanato expects 2025 adjusted EBITDA of €288.5 mln to €301.8 mln

Stevanato projects 2025 adjusted diluted EPS of €0.50 to €0.54

Result Drivers

BDS SEGMENT GROWTH - Revenue from the Biopharmaceutical and Diagnostic Solutions Segment grew 14%, driven by high-value solutions and favorable shipment timing

HIGH-VALUE SOLUTIONS - Revenue from high-value solutions increased 47% to a record €147.9 million, driven by demand for Nexa syringes and EZ-fill vials

SHIPMENT TIMING - Favorable timing of product shipments added approximately €10 million to BDS Segment revenue

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Beat
EUR 303.20 mln
EUR 290.39 mln (9 Analysts)
Q3 EPS
EUR 0.13
Q3 Net Income
EUR 36.10 mln
Q3 Gross Profit
EUR 88.50 mln
Q3 Operating Income
EUR 52.70 mln
Q3 Pretax Profit
EUR 49.10 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"

Wall Street's median 12-month price target for Stevanato Group SpA is $28.00, about 10.7% above its November 5 closing price of $25.00

The stock recently traded at 35 times the next 12-month earnings vs. a P/E of 36 three months ago

Press Release: ID:nBwg7NwCa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)